Skip to content

Clinical study of local application vancomycin powder to prevent the 'implant related infection'

Clinical study of local application vancomycin powder to prevent the 'implant related infection'

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INC-16007777
Enrollment
Unknown
Registered
2016-01-17
Start date
2016-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

closed and open Gusitilo I fractures

Interventions

contorl group:placebo
treatment group:Vancomycin powder

Sponsors

Department of Trauma,The Third Affiliated Hospital of the Third Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. hospitaled patients aged from 18 to 65, both men and women; 2. open Gusitilo I fractures and close fractures; 3. single fracture,fixed with titanium plate; 4. subjects are Voluntary and sign the informed content, attending the research.

Exclusion criteria

Exclusion criteria: 1. The surgical site has infection and surgery history; 2. The time of Open fracture has been over eight hours; 3. Pathological fracture caused by cancer, osteoporosis or other diseases; 4. Multiple fractures or trauma patients; 5. Pregnant or lactating women, or prepare pregnant women; 6. Vancomycin allergy or contraindications; 7.Being Difficult to complete the follow-up, or affect the compliance of various factors; 8. Patient Refusing to sign the informed consent and participate in this research.

Design outcomes

Primary

MeasureTime frame
erythrocyte sedimentation rate;C-reactive protein;interleukin-6;X ray;leukocyte;Neutrophils;Tumor necrosis factor;Procalcitonin;

Countries

China

Contacts

Public ContactFei Jun
feijundoctor@sohu.com+86 13883405501

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026